SEC Filings

SEC Filings

Filing date Description Form Filing Group Issuer View
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
Eidos Therapeutics, Inc.
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
Eidos Therapeutics, Inc.
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Eidos Therapeutics, Inc.
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Eidos Therapeutics, Inc.
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Eidos Therapeutics, Inc.
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Eidos Therapeutics, Inc.
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Eidos Therapeutics, Inc.
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Eidos Therapeutics, Inc.
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Eidos Therapeutics, Inc.
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Eidos Therapeutics, Inc.

Copyright Morningstar